555 filings
Page 3 of 28
8-K
MCRB
Seres Therapeutics Inc
2 Jan 24
Amendments to Articles of Incorporation or Bylaws
4:05pm
SC 13G/A
MCRB
Seres Therapeutics Inc
7 Nov 23
Seres Therapeutics / FEDERATED HERMES ownership change
12:57pm
10-Q
2023 Q3
MCRB
Seres Therapeutics Inc
Quarterly report
2 Nov 23
10:00am
8-K
MCRB
Seres Therapeutics Inc
2 Nov 23
Seres Therapeutics Reports Third Quarter 2023 Financial Results Including VOWST™ Net Sales of $7.6 Million
7:05am
4
Paula Cloghessy
31 Oct 23
Seres Therapeutics / Paula Cloghessy ownership change
9:43pm
4
Eric D. Shaff
31 Oct 23
Seres Therapeutics / Eric D. Shaff ownership change
9:40pm
4
MCRB
Seres Therapeutics Inc
31 Oct 23
Seres Therapeutics / Teresa L. Young ownership change
9:40pm
4
MCRB
Seres Therapeutics Inc
31 Oct 23
Seres Therapeutics / David Arkowitz ownership change
9:39pm
4
MCRB
Seres Therapeutics Inc
31 Oct 23
Seres Therapeutics / Thomas DesRosier ownership change
9:39pm
4
David S. Ege
31 Oct 23
Seres Therapeutics / David S. Ege ownership change
9:39pm
4
Moltke Lisa von
31 Oct 23
Seres Therapeutics / Moltke Lisa von ownership change
9:36pm
4
Matthew R. Henn
31 Oct 23
Seres Therapeutics / Matthew R. Henn ownership change
9:36pm
8-K
MCRB
Seres Therapeutics Inc
4 Oct 23
Departure of Directors or Certain Officers
7:00am
EFFECT
MCRB
Seres Therapeutics Inc
16 Aug 23
Notice of effectiveness
12:15am
UPLOAD
MCRB
Seres Therapeutics Inc
11 Aug 23
Letter from SEC
12:00am
CORRESP
MCRB
Seres Therapeutics Inc
11 Aug 23
Correspondence with SEC
12:00am
S-3
MCRB
Seres Therapeutics Inc
Shelf registration
8 Aug 23
4:07pm
10-Q
2023 Q2
MCRB
Seres Therapeutics Inc
Quarterly report
8 Aug 23
10:01am
8-K
MCRB
Seres Therapeutics Inc
8 Aug 23
Seres Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
7:05am
8-K
MCRB
Seres Therapeutics Inc
28 Jun 23
Amendments to Articles of Incorporation or Bylaws
8:00am